DGX Quest Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NYSE: DGX

Price (delayed)

$135.49

Market cap

$15.9B

P/E Ratio

8.83

Dividend/share

$2.56

EPS

$15.35

Enterprise value

$19.85B

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
DGX's price to earnings (P/E) is 41% lower than its 5-year quarterly average of 14.9
The revenue has grown by 3.3% YoY
DGX's EPS is up by 15% year-on-year but it is down by 3.2% since the previous quarter
The net income has contracted by 6% from the previous quarter but it has grown by 4.4% YoY
Quest Diagnostics's quick ratio has decreased by 20% YoY and by 7% QoQ
Quest Diagnostics's equity has decreased by 5% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.questdiagnostics.com/
Peers: LH BRLI NEO ENZ

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
117.37M
Market cap
$15.9B
Enterprise value
$19.85B
Valuations
Price to earnings (P/E)
8.83
Price to book (P/B)
2.54
Price to sales (P/S)
1.51
EV/EBIT
7.68
EV/EBITDA
6.62
EV/Sales
1.86
Earnings
Revenue
$10.68B
EBIT
$2.59B
EBITDA
$3B
Free cash flow
$1.61B
Per share
EPS
$15.35
Free cash flow per share
$13.49
Book value per share
$53.38
Revenue per share
$89.74
TBVPS
$42.63
Balance sheet
Total assets
$13.44B
Total liabilities
$7.03B
Debt
$4.66B
Equity
$6.38B
Working capital
$775M
Liquidity
Debt to equity
0.73
Current ratio
1.46
Quick ratio
1.23
Net debt/EBITDA
1.32
Margins
EBITDA margin
28.1%
Gross margin
38.2%
Net margin
17.6%
Operating margin
20.9%
Efficiency
Return on assets
14.1%
Return on equity
30%
Return on invested capital
35.5%
Return on capital employed
22%
Return on sales
24.2%
Dividend
Dividend yield
1.89%
DPS
$2.56
Payout ratio
16.7%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
-0.33%
1 week
1.89%
1 month
-1.65%
1 year
0.64%
YTD
-21.69%
QTD
1.89%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$10.68B
Gross profit
$4.08B
Operating income
$2.23B
Net income
$1.88B
Gross margin
38.2%
Net margin
17.6%
The company's operating margin fell by 12% YoY and by 5% QoQ
DGX's operating income is down by 9% year-on-year and by 6% since the previous quarter
The net income has contracted by 6% from the previous quarter but it has grown by 4.4% YoY
Quest Diagnostics's gross margin has decreased by 5% YoY and by 2.1% QoQ

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
P/E
8.83
P/B
2.54
P/S
1.51
EV/EBIT
7.68
EV/EBITDA
6.62
EV/Sales
1.86
DGX's price to earnings (P/E) is 41% lower than its 5-year quarterly average of 14.9
DGX's EPS is up by 15% year-on-year but it is down by 3.2% since the previous quarter
The stock's price to book (P/B) is 12% less than its last 4 quarters average of 2.9
Quest Diagnostics's equity has decreased by 5% YoY
The stock's price to sales (P/S) is 16% less than its 5-year quarterly average of 1.8 and 11% less than its last 4 quarters average of 1.7
The revenue has grown by 3.3% YoY

Efficiency

How efficient is Quest Diagnostics business performance
DGX's return on assets is up by 8% year-on-year but it is down by 4.7% since the previous quarter
DGX's ROE is up by 7% year-on-year but it is down by 4.2% since the previous quarter
Quest Diagnostics's return on invested capital has decreased by 4.6% QoQ but it has increased by 4.4% YoY
DGX's return on sales is down by 4.7% since the previous quarter and by 2% year-on-year

Dividends

What is DGX's dividend history
Dividend details
DPS
$2.56
Dividend yield
1.89%
Payout ratio
16.7%
Recent dividends

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 91% greater than the total liabilities
Quest Diagnostics's quick ratio has decreased by 20% YoY and by 7% QoQ
The current ratio has decreased by 17% YoY and by 6% QoQ
Quest Diagnostics's debt is 27% lower than its equity
The company's debt to equity rose by 6% YoY
Quest Diagnostics's equity has decreased by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.